| P2093 | author name string | W Kisiel | |
| | K J Smith | |
| | D C Foster | |
| | M Iino | |
| | D Bharadwaj | |
| | M Kontoyianni | |
| P2860 | cites work | Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation | Q22254871 |
| | Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis | Q24296938 |
| | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| | Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 |
| | Structure of human des(1-45) factor Xa at 2.2 A resolution | Q27731982 |
| | The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor | Q27732597 |
| | The coagulation cascade: initiation, maintenance, and regulation | Q28610148 |
| | Characterization of a cDNA coding for human factor VII | Q28646329 |
| | Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor | Q34370795 |
| | Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. | Q41657021 |
| | Autoactivation of human recombinant coagulation factor VII. | Q42193518 |
| | Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization | Q42687644 |
| | A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. | Q51340333 |
| | Synthesis, purification, and characterization of an Arg152 .fwdarw. Glu site-directed mutant of recombinant human blood clotting factor VII | Q61314306 |
| | Three-dimensional structure for the β2 adrenergic receptor protein based on computer modeling studies | Q67489693 |
| | Activation of human factor VII by the prothrombin activator from the venom of Oxyuranus scutellatus (Taipan snake) | Q68153623 |
| | Anticoagulant and antithrombotic properties of a gamma-carboxyglutamic acid-rich peptide derived from the light chain of blood coagulation factor X | Q69737601 |
| | Factor VII deficiency: immunological characterization of genetic variants and detection of carriers | Q70820019 |
| | Factor VII deficiency | Q70857125 |
| | Regional mapping of clotting factors VII and X to 13q34. Expression of factor VII through chromosome 8 | Q71326289 |
| | Enzyme immunoassay ELISA and EMIT | Q72153601 |
| | A high-performance liquid chromatographic method for the simultaneous determination of gamma-carboxyglutamic acid and glutamic acid in proteins, bone, and urine | Q72519120 |
| P433 | issue | 48 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 30685-91 | |
| P577 | publication date | 1996-11-29 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity | |
| P478 | volume | 271 | |